{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:57:17Z","timestamp":1793141837699,"version":"4.5.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2020,2,1]]},"DOI":"10.1001\/jamaophthalmol.2019.5403","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T14:12:37Z","timestamp":1577974357000},"page":"182","source":"Crossref","is-referenced-by-count":31,"title":["Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free Survival"],"prefix":"10.1001","volume":"138","author":[{"given":"Manuel","family":"Rodrigues","sequence":"first","affiliation":[{"name":"Unit 830 (Cancer, Heterogeneity, Instability and Plasticity) INSERM, Institut Curie, PSL Research University, Paris, France"},{"name":"Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Ait Rais","sequence":"additional","affiliation":[{"name":"Department of Genetics, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Salviat","sequence":"additional","affiliation":[{"name":"Department of Biometry, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Algret","sequence":"additional","affiliation":[{"name":"Department of Biometry, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatoumata","family":"Simaga","sequence":"additional","affiliation":[{"name":"Department of Genetics, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Barnhill","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Institut Curie, PSL Research University, Paris, France"},{"name":"Faculty of Medicine, University of Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gardrat","sequence":"additional","affiliation":[{"name":"Unit 830 (Cancer, Heterogeneity, Instability and Plasticity) INSERM, Institut Curie, PSL Research University, Paris, France"},{"name":"Department of Biopathology, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Servois","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Mariani","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Piperno-Neumann","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Roman-Roman","sequence":"additional","affiliation":[{"name":"Department of Translational Research, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Delattre","sequence":"additional","affiliation":[{"name":"Unit 830 (Cancer, Heterogeneity, Instability and Plasticity) INSERM, Institut Curie, PSL Research University, Paris, France"},{"name":"Department of Genetics, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cassoux","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Paris Descartes, Paris, France"},{"name":"Department of Ocular Oncology, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Savignoni","sequence":"additional","affiliation":[{"name":"Department of Biometry, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Henri","family":"Stern","sequence":"additional","affiliation":[{"name":"Unit 830 (Cancer, Heterogeneity, Instability and Plasticity) INSERM, Institut Curie, PSL Research University, Paris, France"},{"name":"Department of Genetics, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Pierron","sequence":"additional","affiliation":[{"name":"Department of Genetics, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"eoi190091r1","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2147\/OPTH","article-title":"Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973-2012).","volume":"10","author":"Mahendraraj","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"eoi190091r2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0181-5512(06)73843-8","article-title":"Prognostic factors for malignant uveal melanoma: retrospective study on 2,241 patients and recent contribution of monosomy-3 research [in French].","volume":"29","author":"Desjardins","year":"2006","journal-title":"J Fr Ophtalmol"},{"issue":"9","key":"eoi190091r3","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival.","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi190091r4","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma.","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi190091r6","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-15-2071","article-title":"PRAME as an independent biomarker for metastasis in uveal melanoma.","volume":"22","author":"Field","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"20","key":"eoi190091r7","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","article-title":"Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death.","volume":"64","author":"Onken","year":"2004","journal-title":"Cancer Res"},{"issue":"22","key":"eoi190091r8","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/jnci\/82.22.1765","article-title":"Nonrandom chromosomal abnormalities in primary uveal melanoma.","volume":"82","author":"Prescher","year":"1990","journal-title":"J Natl Cancer Inst"},{"issue":"9010","key":"eoi190091r9","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic implications of monosomy 3 in uveal melanoma.","volume":"347","author":"Prescher","year":"1996","journal-title":"Lancet"},{"issue":"6","key":"eoi190091r10","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/bjophthalmol-2013-303867","article-title":"Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma.","volume":"98","author":"Cassoux","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"eoi190091r11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"issue":"1","key":"eoi190091r12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ccell.2017.12.013","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma.","volume":"33","author":"Robertson","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"eoi190091r13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41467-017-02428-w","article-title":"Punctuated evolution of canonical genomic aberrations in uveal melanoma.","volume":"9","author":"Field","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"eoi190091r14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/gcc.v56.2","article-title":"Germline BAP1 alterations in familial uveal melanoma.","volume":"56","author":"Rai","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"issue":"6009","key":"eoi190091r15","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas.","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"issue":"10","key":"eoi190091r16","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors.","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"issue":"7","key":"eoi190091r17","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/modpathol.2011.51","article-title":"Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma.","volume":"24","author":"Abdel-Rahman","year":"2011","journal-title":"Mod Pathol"},{"issue":"20","key":"eoi190091r18","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"eoi190091r19","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1167\/iovs.08-2296","article-title":"Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases.","volume":"50","author":"Trolet","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"eoi190091r20","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","article-title":"SF3B1 mutations are associated with alternative splicing in uveal melanoma.","volume":"3","author":"Furney","year":"2013","journal-title":"Cancer Discov"},{"issue":"4","key":"eoi190091r21","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.18632\/oncotarget.v7i4","article-title":"Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.","volume":"7","author":"Johansson","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"eoi190091r22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/bjo.2010.181289","article-title":"Chromosomal aberrations in iris melanomas.","volume":"95","author":"Mensink","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi190091r23","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1158\/1078-0432.CCR-06-2401","article-title":"Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma.","volume":"13","author":"Worley","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"10","key":"eoi190091r24","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1167\/iovs.08-2033","article-title":"Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.","volume":"49","author":"van Gils","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"eoi190091r25","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1167\/iovs.11-9027","article-title":"Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array.","volume":"53","author":"Singh","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"eoi190091r26","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1167\/iovs.08-3165","article-title":"Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death.","volume":"50","author":"Damato","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"eoi190091r27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/aos.2014.92.issue-6","article-title":"MicroRNA expression analysis and multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.","volume":"92","author":"Larsen","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"eoi190091r28","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/bjc.2014.417","article-title":"Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing.","volume":"111","author":"Kalirai","year":"2014","journal-title":"Br J Cancer"},{"issue":"12","key":"eoi190091r29","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1136\/bjophthalmol-2014-305047","article-title":"Prognostic parameters in uveal melanoma and their association with BAP1 expression.","volume":"98","author":"van Essen","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"eoi190091r30","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/bjc.2012.54","article-title":"Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study.","volume":"106","author":"Thomas","year":"2012","journal-title":"Br J Cancer"},{"issue":"8","key":"eoi190091r31","first-page":"3439","article-title":"Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma.","volume":"61","author":"Tschentscher","year":"2001","journal-title":"Cancer Res"},{"issue":"2","key":"eoi190091r32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10585-005-5142-2","article-title":"The identification of chromosome abnormalities associated with the invasive phenotype of uveal melanoma in vitro.","volume":"22","author":"Cross","year":"2005","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"eoi190091r33","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ophtha.2010.05.023","article-title":"Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens.","volume":"118","author":"Shields","year":"2011","journal-title":"Ophthalmology"},{"issue":"24","key":"eoi190091r34","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-10-2076","article-title":"Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification.","volume":"16","author":"Damato","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"8","key":"eoi190091r35","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1167\/iovs.13-12195","article-title":"Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome.","volume":"54","author":"Ewens","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi190091r36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/35101031","article-title":"Two genetic hits (more or less) to cancer.","volume":"1","author":"Knudson","year":"2001","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"eoi190091r37","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1038\/s41467-018-04322-5","article-title":"Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors.","volume":"9","author":"Rodrigues","year":"2018","journal-title":"Nat Commun"},{"issue":"18","key":"eoi190091r38","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1158\/1078-0432.CCR-19-1215","article-title":"Evolutionary routes in metastatic uveal melanomas depend on MBD4 alterations.","volume":"25","author":"Rodrigues","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"5-6","key":"eoi190091r39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00251-019-01108-x","article-title":"Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab.","volume":"71","author":"Johansson","year":"2019","journal-title":"Immunogenetics"},{"issue":"1","key":"eoi190091r40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/bjophthalmol-2016-309034","article-title":"Metastatic disease from uveal melanoma: treatment options and future prospects.","volume":"101","author":"Carvajal","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"15","key":"eoi190091r41","doi-asserted-by":"publisher","first-page":"9502","DOI":"10.1200\/JCO.2017.35.15_suppl.9502","article-title":"A randomized multicenter phase 3 trial of adjuvant fotemustine versus surveillance in high risk uveal melanoma (UM) patients (FOTEADJ).","volume":"35","author":"Piperno-Neumann","year":"2017","journal-title":"J Clin Oncol"},{"issue":"5","key":"eoi190091r42","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/modpathol.2017.187","article-title":"Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.","volume":"31","author":"Smit","year":"2018","journal-title":"Mod Pathol"},{"issue":"2","key":"eoi190091r43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/tvst.8.2.18","article-title":"Next-generation sequencing of uveal melanoma for detection of genetic alterations predicting metastasis.","volume":"8","author":"Afshar","year":"2019","journal-title":"Transl Vis Sci Technol"},{"issue":"8","key":"eoi190091r44","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081173","article-title":"Comparative cytogenetic abnormalities in paired choroidal melanoma samples obtained before and after proton beam irradiation by transscleral fine-needle aspiration biopsy and endoresection.","volume":"11","author":"Matet","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"7","key":"eoi190091r45","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41588-019-0440-9","article-title":"The genetic evolution of metastatic uveal melanoma.","volume":"51","author":"Shain","year":"2019","journal-title":"Nat Genet"},{"issue":"8","key":"eoi190091r46","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/bjophthalmol-2017-310361","article-title":"Prognostic biopsy of choroidal melanoma: an optimised surgical and laboratory approach.","volume":"101","author":"Angi","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"eoi190091r5","volume-title":"The TNM Classification of Malignant Tumours","author":"Brierley","year":"2016","edition":"8th ed"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2757831\/jamaophthalmology_rodrigues_2020_oi_190091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T11:00:48Z","timestamp":1581591648000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2757831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.5403","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,1]]}}}